Viracta Therapeutics Company
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Technology:
Cancer, Tumor-Specific Antigens
Industry:
Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics
Headquarters:
Cardiff By The Sea, California, United States
Founded Date:
2007-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
21
Total Funding:
184899999
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-11-05
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership